Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Name: Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Published: 2022
License: Public Domain

Theodore S. Johnson · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

glioblastoma immunotherapy pediatric

ependymoma, medulloblastoma, glioblastoma, primary brain tumor, ido, indoleamine 2,3-dioxygenase, indoximod, btk, bruton's tyrosine kinase, ibrutinib, immunotherapy, pediatric

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 807820
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.